Status:
TERMINATED
LOSS- Louisiana Obese Subjects Study
Lead Sponsor:
Pennington Biomedical Research Center
Collaborating Sponsors:
Louisiana Office of Group Benefits
Conditions:
Obesity
Eligibility:
All Genders
20-60 years
Phase:
PHASE4
Brief Summary
LOSS is a pragmatic clinical evaluation of intensive medical approaches to weight loss for individuals with extreme obesity (body mass index \[BMI\] 40-60 kg/m2). The intensive medical treatment is de...
Detailed Description
LOSS is a pragmatic clinical trial designed to evaluate intensive medical treatment for patients with severe obesity who would otherwise qualify as candidates for obesity surgery and who are covered b...
Eligibility Criteria
Inclusion
- Participant in the Exclusive Provider Organization (EPO), Managed Care Organization (MCO) and Preferred Provider Organization (PPO) programs of the Louisiana State Employees Group Benefits Health Insurance
- Agree to travel for treatment to the assigned study site
- Agree to randomized treatment assignment
- Male and females age 20-60 years
- Body Mass Index \>40kg/m2 but \< 60 kg/m2
- Females must be non-pregnant and using an approved contraception method
- Complete Blood Count (CBC): normal hematocrit, white count and platelet count, unless waived by Principal Investigator (PI)
- Uric Acid \<9.0 mg/dl
- Normal Creatinine
- Normal Thyroid Stimulating Hormone (TSH)
- Negative urine pregnancy test for women of childbearing potential
- Able to give written informed consent
- Able to comply with study procedures
Exclusion
- Factors that may limit adherence to interventions or affect conduct of the trial:
- Unable or unwilling to give informed consent or communicate with local study staff
- Hospitalization for psychiatric illness or substance use/abuse within the past year
- Self-report of alcohol or substance abuse within the past twelve months
- Current major depressive episode or history of suicidal behaviors
- Endorsement of significant recent suicidal ideation (as determined by PI)
- Travel plans that do not permit participation
- History of prior bariatric surgery, small bowel resection, or extensive bowel resection
- Current use of chronic systemic corticosteroids, appetite suppressants, antipsychotic medication, herbal medications for weight loss or any medication not approved by the PI.
- Another member of the household is a participant or staff member in the study
- History of eating disorder such as anorexia nervosa, bulimia, or binge eating
- Diagnosis of schizophrenia, other psychotic disorders, bipolar disorder, or personality disorder (as determined by the PI)
- Currently pregnant or nursing or plans to become pregnant in the next five years
- Except for non-melanoma skin cancer, cancer requiring treatment in the past five years, unless the prognosis is excellent
- Self report of Human Immunodeficiency Virus (HIV) positive, hepatitis C or active tuberculosis
- Cardiovascular disease event within the past year
- Severe congestive heart failure (New York Heart Association \[NYHA\] Functional Class III, IV)
- Second degree or greater heart block
- Blood Pressure \>160 systolic or \>100 diastolic on two consecutive visits, unless treated and re-screened
- Based upon responses to psychological screening or an interview, patients may be excluded by the study psychologist.
- Other medical, psychiatric, or behavioral limitations that in the judgment of the investigator may interfere with study participation or the ability to follow the intervention protocol.
- Pregnancy is to be avoided during the study. Women who have not had a hysterectomy or oophorectomy must have a negative urine pregnancy test result at screening. Women of childbearing potential will be allowed to participate if they have undergone tubal ligation, or use one of the following types of contraception: properly used condom or diaphragm, oral contraceptives, hormonal implant, or intrauterine device (IUD). Sexual abstinence may constitute an acceptable birth control method for this study with investigator approval. Women with male partners who have had a successful vasectomy (more than one year of unprotected sexual intercourse without pregnancy) are not required to use additional birth control methods as long as the relationship remains exclusive, and the woman agrees to use an approved contraception method with any other male partner. Questions regarding individual patient contraceptive practices should be directed to the Principal Investigator.
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
390 Patients enrolled
Trial Details
Trial ID
NCT00115063
Start Date
July 1 2005
End Date
January 1 2008
Last Update
February 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pennington Management of Clinical Trials
Baton Rouge, Louisiana, United States, 70808